Hadassah Cancer Research Institute

Lab description

The Hadassah Cancer Research Institute (HCRI) is devoted to translational research in the field of oncology.

Harnessing Hadassah’s clinical excellence for cutting edge immuno-oncology research, the center provides pre-clinical services to the industry. Among the services there are customized in vitro and in vivo assays for testing novel anti-cancer therapies, clinical consulting, early-stage clinical trials management and human samples collection.


  • Skilled team of physician-scientists
  • Intense clinical-academia collaborations with the Hebrew University Faculty of Medicine
  • Big data silos
  • Biobank generated in a busy tertiary Oncology Institute
  • Research partner in MIDGAM – The Israeli Biorepository Network for Research

HCRI Leadership

Prof. Michal Lotem

Prof. Aaron Popovtzer

Dr. Aviad Zick

Dr. Shai Rosenberg

Dr. Yakir Rotenberg

Dr. Sharon Merims

Dr. Yonatan Cohen

Dr. Albert Grinshpun

Dr. Boaz Nahmias

Dr. Shani Paluh Simon

Dr. Tal Falich Michaeli

HCRI's centers of research excellence

Developing next generation tools & therapies
for faster cancer diagnosis and cure
  • Immuno Oncology
  • Cancer Epigenetics
  • Cell Therapy
  • Bioinformatics
  • Precision Radiotherapy
  • Biobank
  • Computational Biology
  • Phase I Clinical Studies Unit
  • Cancer Prevention And Early Detection